Cancer Causing Agents - Carcinogens (cont.)

Because of the importance of cancer and agents which may cause it, we here provide some of the highlights of this Report.

Listing in the Report

A listing in the Report does not by itself establish that a substance presents a cancer risk to an individual in daily life.

The Report also does not try to balance the potential benefits of exposures to certain carcinogenic substances in special situations. For example, a number of drugs used to treat cancer have been shown to increase the occurrence of secondary cancers. In these instances, the benefits of exposure to the drugs for treatment or prevention of a specific disease have been determined by the Food & Drug Administration (FDA) to outweigh the additional cancer risks associated with their use. People should not make decisions concerning the use of a given drug, or any other listed agent, based solely on the information contained in the Report. Decisions of this type should be made only after consulting with a physician or other appropriate specialist about both risks and benefits.

"Known" versus "Reasonably Anticipated" To Be a Carcinogen

An agent or exposure can be listed in the Report as "known to be a human carcinogen" or as "reasonably anticipated to be a human carcinogen."

The "known" category is reserved for those substances for which there is sufficient evidence of carcinogenicity from studies in humans that indicates a cause and effect relationship between the exposure and human cancer.

The "reasonably anticipated" category includes those substances for which there is limited evidence of carcinogenicity in humans and/or sufficient evidence of carcinogenicity in experimental animals.

Six substances have been added to the "known" category:

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) are viruses that cause acute or chronic liver disease. They are listed in the report as "known human carcinogens" because studies in humans show that chronic hepatitis B and hepatitis C infections cause liver cancer. Approximately one million United States residents are chronically infected with HBV, which primarily is transmitted through sexual contact (50%) and intravenous drug use (15%).

HCV is the leading cause of liver disease in the United States with more than three million people infected. The major risk factor for hepatitis C infection is illegal intravenous drug use, which accounts for 60 percent of acute infections in adults. The incidence of both hepatitis B and hepatitis C infections is decreasing among United States residents. A vaccine is available for preventing hepatitis B infection but not hepatitis C infection. Infections can also be prevented by screening blood supplies, and by reducing contact with contaminated fluids in health care settings.

  • Human papillomaviruses (HPVs) are viruses that are sexually transmitted and can infect genital and mucous membranes. Some of these genital mucosal type HPVs are listed in the report as "known human carcinogens" because studies show they cause cervical cancer in women. Approximately 20 million people in the United States are infected with genital HPVs, and 5.5 million new infections occur each year. Most people infected do not have symptoms, but some develop genital warts or cervical abnormalities.
  • X-radiation and gamma-radiation are listed in the report as "known human carcinogens" because human studies show that exposure to these kinds of radiation causes many types of cancer including leukemia and cancers of the thyroid, breast and lung. The risk of developing cancers due to these forms of ionizing radiation depends to some extent on age at the time of exposure. Childhood exposure is linked to an increased risk for leukemia and thyroid cancer. Exposure during reproductive years increases the risk for breast cancer, and exposure later in life increases risk for lung cancer. Exposure to X-radiation and gamma radiation has also been shown to cause cancer of the salivary glands, stomach, colon, bladder, ovaries, central nervous system and skin.

Health Solutions From Our Sponsors